Intelligence · Clinical pipeline
Neurology & CNS · Phase III
Neurology & CNS programs at Phase III — ClinicalTrials.gov pipeline intelligence.
Quick answer
Neurology & CNS Phase III programs: NovaPharmaNews indexes 15 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- HOFFMANN-LA ROCHE 21 programs
- Teva Pharma 12 programs
- Novartis India 10 programs
- Takeda 10 programs
- Bristol-Myers Squibb Australia 9 programs
- Jazz Pharmaceuticals Ireland 7 programs
- Biogen 6 programs
- TG THERAPEUTICS 6 programs
- Acadia Pharmaceuticals 5 programs
- Anaxis Pharma 5 programs
- NEUROCRINE BIOSCIENCES 5 programs
- SUPERNUS PHARMACEUTICALS 5 programs
Pipeline programs
-
ALKS 9072, Low Dose
Alkermes Pharma Ireland
Schizophrenia
1 trial -
Aripiprazole IM Depot
Otsuka Beijing Research Institute
Schizophrenia
1 trial -
Asenapine Sublingual Tablets 10 mg
Amneal Pharma Europe Ltd
Schizophrenia
1 trial -
LB-102
LB PHARMACEUTICALS INC
Schizophrenia
4 trials -
LB-102 (50 mg tablet)
LB PHARMACEUTICALS INC
Schizophrenia
1 trial -
NBI-1117568
NEUROCRINE BIOSCIENCES INC
Schizophrenia
5 trials -
NBI-98854-ATS3019
NEUROCRINE BIOSCIENCES INC
Schizophrenia
1 trial -
Paliperidone palmitate
Janssen Cilag International NV
Schizophrenia
2 trials -
Phase 1: Olanzapine
Shanghai Mental Health Center
Schizophrenia
1 trial -
Pimavanserin
Acadia Pharmaceuticals B.V.
Schizophrenia
4 trials -
Placebo
NEUROCRINE BIOSCIENCES INC
Schizophrenia
2 trials -
Placebo
Hoffmann-La Roche
Schizophrenia
1 trial -
RBP-7000
Indivior Pty Ltd
Schizophrenia
5 trials -
TV-44749
Teva Pharma GmbH
Schizophrenia
3 trials -
Xanomeline and Trospium Chloride Capsules
Bristol-Myers Squibb Australia Pty Ltd
Schizophrenia
1 trial
Frequently asked questions
How many neurology & cns Phase III programs exist?
15 programs match both the therapeutic area and stage filters in our published index.